We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.72
Bid: 3.60
Ask: 3.84
Change: -0.10 (-2.62%)
Spread: 0.24 (6.667%)
Open: 3.82
High: 0.00
Low: 0.00
Prev. Close: 3.82
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Approval of PHC68949 in Mexico

4 Apr 2024 07:00

RNS Number : 2218J
Plant Health Care PLC
04 April 2024
 

4 April 2024

 

Plant Health Care plc

 ("Plant Health Care" or the "Company")

 

Mexico approves PHC68949 to Control Nematodes in Vegetable Crops

  

Plant Health Care® (AIM.PHC.L), a leading provider of peptides used by growers to improve crop production and quality within global agriculture markets, is pleased to announce COFEPRIS registration and pending commercial launch of the biological nematode control product PHC68949 in Mexico.

 

Highlights

- PHC68949 is a novel product that amplifies a plant's natural defense pathways to provide protection within the rhizosphere to protect plant roots from parasitic nematodes, promoting crop yield and harvest quality.

- The Company plans a limited launch of PHC68949 in the second half of 2024 to build grower and distributor awareness, followed by a full commercial launch through its most important distributors in 2025. The brand name will be announced closer to the launch date.

- PHC68949 will initially be applied via drench and foliar applications on tomatoes, eggplants, peppers and other Solanaceae crops as well as cucumbers and other Cucurbit crops in Mexico.

 

As a next generation bionematicide, PHC68949 increases plant health and yield across a wide range of commercial crops. Results from field studies confirm efficacy from foliar applications of PHC68949 is comparable to synthetic chemical nematicides and superior to current biological products. PHC68949 provides growers with a low use rate, environmentally friendly option with a novel mode of action to displace established synthetic chemical nematicides and improve crop yield and harvest quality. PHC68949 provides growers with consistent performance and convenience as it does not have label limitations commonly associated with synthetic chemical nematicides and is exempt from Maximum Residue Limit (MRL) restrictions, providing greater access to high value export markets. Product launch will focus on control of southern root-knot nematode (Meloidogyne incognita) in Solanaceae and Cucurbit crops, with additional claims on other crops and nematode species to follow in the future.

 

Mexico currently plants 48,000 hectares of tomato and 150,000 hectares of peppers per year. Mexico produced 1.2 million metric tons of watermelon in 2023 and is the world's largest exporter of cucumbers. Production of cucumbers in Mexico is expected to reach 1.02 million metric tons by 2026. In 2022, the plant-applied biopesticides market in Mexico, which includes both biofungicides and bionematicides, was estimated at $200 million, growing at a CAGR of 14.3%.

 

The Company submitted the PHC68949 application for regulatory review to the Federal Committee for Protection from Sanitary Risks (COFEPRIS) in September 2023 based on a comprehensive data package. The regulatory process in Mexico for agricultural products involves a detailed and comprehensive review of standard safety and performance data including replicated small plot field trials to confirm product efficacy. 

 

PHC68949 is a novel product based on the Company's innovative PREtec technology platform. Derived from natural proteins, PREtec is an environmentally friendly technology which stimulates plant defense and pathogen resistance mechanisms within plants. Years of research, field testing, and commercial experience have confirmed that PREtec products deliver improved crop growth, harvest quality, and grower profitability. 

 

Compared with alternative biological products, PHC68949 brings highly consistent product efficacy across a broad spectrum of application and environmental conditions and is compatible with fungicides, herbicides, and insecticides in tank-mix and sequential application systems. PHC68949 has a two-year shelf-life with no special requirements for storing or handling, which allows greater flexibility within the distribution channel and ease of on-farm application.

  

Jeff Tweedy, CEO of Plant Health Care, said: ‟Following the approval last month of our SAORI biofungicide, I am excited to announce the approval of PHC68949 for nematode control. The planned launch of both PHC68949 and SAORI in Mexico later this year culminate years of hard work undertaken by the Company to demonstrate the safety, efficacy, and value that both products bring to the market. We continue to scale the PREtec pipeline of products into new markets that will offer growers sustainable technology for the land and consumers.

 

"The approval of PHC68949 supports the Company's vision to be a leading global provider of alternatives to conventional synthetic agrochemicals. We are excited about the developing plans to launch PHC68949 in 2024, with strong growth thereafter."

  

# # #

 

 

For further information, please contact: 

Plant Health Care plc Jeff Tweedy, CEO

 

Tel: +1 919 926 1600

Cavendish Capital Markets Limited - Nomad & Broker Neil McDonald / Pete Lynch

Tel: +44 (0) 131 220 9771

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, sugarcane, potatoes, rice, and wheat, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors, and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAMZGGDVFMGDZM
Date   Source Headline
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.